Clinical Advances in Heart Failure, Cardiogenic Shock and Pulmonary Hypertension Symposium is organized by \u00a0and will be held from Apr 25 \u2013 26, 2025 at San Diego Marriott La Jolla, La Jolla, California, United States of America.<\/p>\n
Description:<\/strong> Educational Objectives:<\/strong> Clinical Advances in Heart Failure, Cardiogenic Shock and Pulmonary Hypertension Symposium is organized by \u00a0and will be held from Apr 25 \u2013 26, 2025 at San Diego Marriott La Jolla, La Jolla, California, United States of America. Description: Significant advances in the diagnosis and management of heart failure and pulmonary hypertension continue to emerge, compelling […]<\/p>\n","protected":false},"featured_media":7777,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[66,15],"product_tag":[],"class_list":{"0":"post-7776","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-course","7":"product_cat-uncategorized","9":"first","10":"instock","11":"sale","12":"downloadable","13":"virtual","14":"purchasable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/cardiologylibrary.com\/index.php?rest_route=\/wp\/v2\/product\/7776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cardiologylibrary.com\/index.php?rest_route=\/wp\/v2\/product"}],"about":[{"href":"https:\/\/cardiologylibrary.com\/index.php?rest_route=\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/cardiologylibrary.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7776"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cardiologylibrary.com\/index.php?rest_route=\/wp\/v2\/media\/7777"}],"wp:attachment":[{"href":"https:\/\/cardiologylibrary.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7776"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/cardiologylibrary.com\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_brand&post=7776"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/cardiologylibrary.com\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_cat&post=7776"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/cardiologylibrary.com\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_tag&post=7776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nSignificant advances in the diagnosis and management of heart failure and pulmonary hypertension continue to emerge, compelling the practice of\u00a0to constantly evolve. These advances must be consistently implemented into clinical practice to guarantee the best care for patients affected by these conditions. The Clinical Advances in Heart Failure, Cardiogenic Shock and Pulmonary Hypertension Symposium is designed to assist clinicians in correctly diagnosing, treating, and managing patients with heart failure and related conditions. In addition, the symposium will outline optimal strategies for managing cardiogenic shock as well as new and emerging techniques for diagnosing and treating various cardiomyopathies. The symposium is dedicated to providing insight and practical tips with regard to integrating scientific evidence into clinical practice. The goal of the conference is for participants to return to their facilities equipped with the latest evidence base and strategies to improve patient outcomes.<\/p>\n
\nAfter attending this live activity, participants should be able to:<\/p>\n\n
2025 Clinical Advances in Heart Failure, Arrhythmias & Cardiogenic Shock Symposium \u2013 Topics & Runtime<\/strong><\/h3>\n
\n\n
\n \nNo.<\/th>\n Topic<\/th>\n Runtime<\/th>\n<\/tr>\n<\/thead>\n \n 1<\/td>\n How to PERT<\/td>\n 15:50<\/td>\n<\/tr>\n \n 2<\/td>\n Hemodynamically Unstable Pulmonary Embolism<\/td>\n 15:09<\/td>\n<\/tr>\n \n 3<\/td>\n Arrhythmias & Palpitations in Women<\/td>\n 18:04<\/td>\n<\/tr>\n \n 4<\/td>\n Racial & Gender Disparities in Cardiac Device Selection<\/td>\n 15:07<\/td>\n<\/tr>\n \n 5<\/td>\n The Language of Shock: SCAI Staging System<\/td>\n 14:32<\/td>\n<\/tr>\n \n 6<\/td>\n Which Device for Which Patient: When to Escalate<\/td>\n 12:43<\/td>\n<\/tr>\n \n 7<\/td>\n About Cardiorenal Syndrome<\/td>\n 15:39<\/td>\n<\/tr>\n \n 8<\/td>\n Cardio-Oncology: Immune Checkpoint Inhibitor\u2013Associated Myocarditis<\/td>\n 18:41<\/td>\n<\/tr>\n \n 9<\/td>\n Basic Principles in Management of Adults with Congenital Heart Disease<\/td>\n 16:23<\/td>\n<\/tr>\n \n 10<\/td>\n Treatment of Cardiac Sarcoid<\/td>\n 15:39<\/td>\n<\/tr>\n \n 11<\/td>\n Remote Titration in Heart Failure to Optimize GDMT: Novel or Needed?<\/td>\n 10:43<\/td>\n<\/tr>\n \n 12<\/td>\n Population Health and Heart Failure: Addressing the Implementation Gap<\/td>\n 11:45<\/td>\n<\/tr>\n \n 13<\/td>\n Exercise Hemodynamics<\/td>\n 17:34<\/td>\n<\/tr>\n \n 14<\/td>\n Device-Based Therapies for HFrEF: Beyond CRT-D?<\/td>\n 15:31<\/td>\n<\/tr>\n \n 15<\/td>\n Advanced Imaging in the Diagnosis of Cardiomyopathies<\/td>\n 14:42<\/td>\n<\/tr>\n \n 16<\/td>\n What\u2019s New in HFpEF Trials<\/td>\n 15:27<\/td>\n<\/tr>\n \n 17<\/td>\n HFpEF and Pulmonary Venous Hypertension<\/td>\n 13:40<\/td>\n<\/tr>\n \n 18<\/td>\n GDMT in CKD and Emerging Therapies for Fluid Balance<\/td>\n 16:17<\/td>\n<\/tr>\n \n 19<\/td>\n HF with Preserved Ejection Fraction in Women<\/td>\n 12:44<\/td>\n<\/tr>\n \n 20<\/td>\n Obesity in HFpEF and Afib<\/td>\n 15:30<\/td>\n<\/tr>\n \n 21<\/td>\n Group III and IV Pulmonary Hypertension<\/td>\n 21:21<\/td>\n<\/tr>\n \n 22<\/td>\n Hypertrophic Cardiomyopathy: Mimickers and Treatment<\/td>\n 19:59<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"